Consent Tracking for Clinical Samples

Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.    In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.  <p> </p> <p>She describes:</p> <ul><li>How consent is or has been documented</li> <li>The benefits of electronic consent documentation</li> <li>Specific consent attributes, e.g. genetic testing</li> <li>Handling consent requirements from different countries or institutions</li> <li>Understanding consent for future use, including limitations and expirations</li> </ul> <p>Learn more at <a href='https://www.q2labsolutions.com/labmatrix'>https://www.q2labsolutions.com/labmatrix</a></p>